μ-δ opioid receptor heteromer-specific signaling in the striatum and hippocampus

Biochem Biophys Res Commun. 2014 Jul 18;450(1):906-11. doi: 10.1016/j.bbrc.2014.06.099. Epub 2014 Jun 26.

Abstract

The μ-δ opioid receptor heteromer activates the pertussis toxin-resistant Gαz GTP-binding protein following stimulation by the δ-agonist deltorphin-II whereas μ- and δ-receptors activate the pertussis toxin-sensitive Gαi3 protein following stimulation by μ- and δ-agonists, respectively. Although the regulation of the μ-δ heteromer is being investigated extensively in vitro, its physiological relevance remains elusive owing to a lack of available molecular tools. We investigated μ-δ heteromer signaling under basal conditions and following prolonged morphine treatment in rodent brain regions highly co-expressing μ- and δ-receptors and Gαz. Deltorphin-II induced Gαz activation in the striatum and hippocampus, demonstrating the presence of μ-δ heteromer signaling in these brain regions. Prolonged morphine treatment, which desensitizes μ- and δ-receptor function, had no effect on μ-δ heteromer signaling in the brain. Our data demonstrate that μ-δ heteromer signaling does not desensitize and is regulated differently from μ- and δ-receptor signaling following prolonged morphine treatment.

Keywords: Brain; GTPγS; Gα(z); Heterooligomer; δ opioid receptor; μ opioid receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analgesics, Opioid / pharmacology
  • Animals
  • Corpus Striatum / drug effects
  • Corpus Striatum / metabolism*
  • Dimerization
  • Hippocampus / drug effects
  • Hippocampus / metabolism*
  • Male
  • Morphine / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Opioid, delta / metabolism*
  • Receptors, Opioid, mu / metabolism*
  • Signal Transduction / drug effects
  • Signal Transduction / physiology*
  • Tissue Distribution / drug effects

Substances

  • Analgesics, Opioid
  • Receptors, Opioid, delta
  • Receptors, Opioid, mu
  • Morphine